Sleepwalking Disorder
Cluster Number:
Wiki Number: PW207
Diagnosis: Sleepwalking Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset: 5% in children; 1.5% in adults in a study had been sleep-walking once in the past 12 months
Brain Area: differently metabolized serotonin
Symptoms: Wakeful activities during slow-wave sleep from talking to eating to driving a car-little or no memory later; 30 seconds to 30 minutes
Progression: occurs early in the sleep-cycle; only once per night, often accompanied by night-terrors especially in children
Causes: sometimes schizophrenia, anxiety disorders, migraines or Tourette syndrome, Parkinson’s, may be genetic or overly tired
Medications: antidepressants, serotonergic agents, antipsychotics ; Sleepwalking has sometimes been an effective defense against crimes.
Therapies: hypnosis, relaxation training,conditioning therapies. For safety, have ground floor bedroom, “alarm” the door, no weapons.
Youtube Video: Is It Dangerous To Wake Up A Sleepwalker?
I found no books with “Sleepwalker” in the title that were medically-based. They were all novels.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Sleep Disordersby Keisuke Suzuki on December 2, 2024
Insomnia is a common sleep disorder that, owing to difficulties falling asleep or maintaining sleep and/or early morning awakening, causes daytime functional impairment. Other sleep disorders include sleep-related breathing disorders; sleep-related movement disorders, such as periodic limb movement disorder and restless legs syndrome; parasomnias, such as rapid eye movement sleep behavior disorder and sleepwalking; and central disorders of hypersomnolence, such as narcolepsy. This article...
- Sleep related injury and its correlates in isolated rapid eye movement sleep behavior disorderby Yuhua Yang on November 30, 2024
CONCLUSIONS: SRI is common in patients with iRBD and 18 % had pSRI despite intensive treatment, emphasizing the importance of bedside safety. The identification of risk factors for SRI and pSRI underscores the need for systematic clinical screening and targeted interventions for at-risk patients.
- Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS databaseby Xiaodan Zhou on November 26, 2024
CONCLUSION: The majority of observed adverse reactions in this study were consistent with those listed in the product instructions. However, potential novel or notable ADE signals were identified through real-world pharmacovigilance analysis. It is anticipated that this paper will offer additional information regarding safe and rational medication for narcolepsy.
- Spectral Dynamics Prior to Motor Events Differ Between NREM Sleep Parasomnias and Healthy Sleepersby Anna Castelnovo on October 25, 2024
CONCLUSIONS: Our findings suggest that the arousal process is altered in DOA patients, and that specific EEG patterns are required for DOA episodes to emerge. These insights will help guide future research into the underlying circuits and objective markers of DOA.